Business Wire

Seoul Semiconductor and Toshiba Materials Taking LEDs Back to Nature

Del

Combining Seoul Semiconductor’s patented LED chip technology & Toshiba Materials’ TRI-R phosphor technology, SunLike Series LEDs deliver the world’s best light quality in a next-generation LED that enables human-centric lighting optimized for circadian rhythms

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170628005183/en/

Chung Hoon Lee, Founder and CEO of Seoul Semiconductor Co., Ltd. (Photo: Business Wire)

Chung Hoon Lee, Founder and CEO of Seoul Semiconductor Co., Ltd. (Photo: Business Wire)

Seoul Semiconductor, a global innovator of LED products and technology, has developed a new LED technology that produces light that closely matches the spectrum of natural sunlight. Announced at a press conference in Frankfurt, Germany on June 26, 2017, the new SunLike Series natural spectrum LED technology was co-developed by Seoul Semiconductor and Toshiba Materials.

Back to natural light

Human beings have lived under natural sunlight for tens of thousands of years, and only began using lanterns in the third century BCE. The use of white LEDs for general illumination began less than 20 years ago, but has spread rapidly around the world due to the high efficiency and cost savings of LED lighting. However, low cost and brightness has been given priority over the quality of light, thus the light from conventional LEDs has a different characteristic from that of natural sunlight, which matches the human biorhythm.

The SunLike Series LED technology closely matches the spectrum of natural sunlight that human have enjoyed for thousands of years. It maximizes the advantage of natural light and minimizes the shortcomings of artificial light sources, providing light more like natural sunlight. This natural spectrum of light is achieved by combining Seoul Semiconductor’s world-class LED chip technology with Toshiba Materials’ TRI-R technology, a leading global phosphor compound.

“Mr. Kumpei Kobayashi, CEO of Toshiba Materials said that “We are pleased to be partnered with a global LED leader like Seoul Semiconductor to introduce the SunLike Series natural spectrum LEDs, which represent an advanced technology that creates a more intimate and nature-based lighting environment.”

“We are pleased to introduce another South Korean innovation in LED technology with the launch of the SunLike Series LED lighting technology that produces light close to the spectrum of natural sunlight. Much like our package-less WICOP Series LEDs revolutionized the LED packaging process, our SunLike Series LEDs represents a revolution in creating natural spectrum LED lighting.” said Mr. Chung Hoon Lee, CEO of Seoul Semiconductor. “The SunLike Series LEDs will be applied in the lighting sector, contributing to a better and healthier life for humans. They will also be used in horticultural applications to create an ideal environment to help plants grow which is safer than using genetic modification,” he added.

He also said “We are delighted to partner with Toshiba Materials to provide our customers a light source that delivers the natural spectrum of sunlight – from the brightness of morning sunshine, to the energy of daylight, to the warmth of an evening sunset. We believe that the SunLike Series LEDs will improve the quality of human life by advancing a new era of human-centric lighting technology.”

Minimizing the side-effects of blue light

Because SunLike Series LEDs are designed to deliver light that closely matches the natural spectrum of sunlight, they provide an optimized light source for human centric lighting that maximizes benefits of natural light while minimizing the negative side effects of artificial light sources.

Some recent studies from Harvard1 and other major universities have suggested that blue LED chips, used in most commercial LEDs to create visible light, provide positive stimulation to the human eye that increases alertness and elevates mood when viewed during daytime hours. However, these blue LEDs create a blue light “spike” in the light output of an LED that may produce negative effects when viewed for prolonged periods during night-time hours by interfering with natural human biorhythms. The SunLike Series natural spectrum LED technology employs a purple LED in conjunction with the TRI-R phosphor compound to minimize the blue light “spike” that is characteristic of typical LED light sources, producing a light output that closely matches the spectrum of natural sunlight to deliver a healthier light experience.

SunLike’s world-class color reproduction

According to the results of published research in academic journals such as Nature2, because humans have lived under the sun for thousands of years, human organs and biorhythms have evolved to respond most appropriately to natural sunlight. Human retinal cells that interpret and respond to color-related light input are composed of red, blue, and green cones, and the percentage of blue receptors was only 5.7%.

Because the amount of blue light that our eyes can accept is limited, blue light above the limit entering the eye is scattered. When this scattering phenomenon occurs, the light is diffused, and as a result, the texture and color of objects are distorted. Also, excess blue light can over-stimulate these retinal cells in the eye, and may cause eyestrain and loss of concentration. However, since SunLike Series LEDs implement the spectrum closest to the sunlight, they more accurately represent the color and texture of the object in natural light without the negative effects of excessive blue light on the eye or human biorhythms. Several products in which Toshiba’s TRI-R technology were incorporated have already been applied to lighting in Milan Fashion Week and illuminating fine art paintings in museum settings.

Applications and Market Forecast

SunLike will primarily be applied in commercial facilities that need to distinguish or show the exact color of the product as seen under sunlight, such as department stores, fine jewelers, horticulture facilities for growing plants indoors, exhibition facilities such as museums and exhibition halls, cosmetic facilities such as dressing rooms or bathrooms.

The global lighting market is estimated at $87 billion, with LED lighting accounting for ~$35 billion. The overall segment of the LED market where the SunLike Series LEDs can be applied represents ~$17 billion. It is anticipated that the SunLike Series natural spectrum LEDs will find initial sales in applications that require high quality lighting, and will eventually be applied in the general lighting market.

The SunLike Series natural spectrum LEDs are available from Seoul Semiconductor. To learn more about the SunLike Series natural spectrum LEDs, please visit: http://www.seoulsemicon.com/en/technology/Sunlike/

For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

1 Blue Light Articles (Source: Harvard Medical School)

http://www.health.harvard.edu/staying-healthy/blue-light-has-a-dark-side

2Source: http://www.nature.com/nature/journal/v397/n6719/full/397520a0.html

*Nature paper number: Roorda et al. Nature, 397, 520-522, (1999)

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as Wicop – a simpler structured package-free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, includes all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves over ten times the output of conventional LEDs. For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com.

About Toshiba Materials

Toshiba Materials Co., Ltd. (http://www.toshiba-tmat.co.jp/eng/) was demerged from Toshiba Corporation in 2003. With material design technology as a core, Toshiba Materials has supplied key material and key components which support the development of society.

Main products are metallic materials, components, fine ceramics parts, and chemical materials. During the year ended March 31, 2017, the company’s net sales totaled ~$127MM (14 billion yen).

# Trademarks

Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

TRI-R is trademark of Toshiba Materials Co.

Contact information

Seoul Semiconductor GmbH
Europe
Ariane Heim
Tel: +49 (0)89 450 3690-0
Email: press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
David Cox
Tel: +1 (919) 410-9856
Email: David.cox@seoulsemicon.com
or
Asia
Seoul Semiconductor Co., Ltd
Jake Jung
Tel: +82 070.4391.8270
Email: pr@seoulsemicon.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) from EMA in Newly Diagnosed Multiple Myeloma21.11.2017 14:40Pressemelding

Janssen-Cilag International NV today announced the submission of a Type II variation application to the European Medicines Agency (EMA), for the immunotherapy DARZALEX®▼ (daratumumab). The application seeks to broaden the existing marketing authorisation to include daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. “This submission to health authorities takes us one step closer to our goal of redefining combination therapy in multiple myeloma, with the potential to make daratumumab available to more patients throughout the treatment continuum: from newly diagnosed, to heavily pre-treated,” said Dr Catherine Taylor, Haematology Therapeutic Area Lead, Janssen Europe, Middle East and Africa (EMEA). “We look forward to working closely with the

Andersen Global Announces Expansion in Uganda21.11.2017 14:30Pressemelding

Andersen Global is proud to announce a presence in Uganda by way of a Collaboration Agreement with Ligomarc Advocates, a financial and corporate tax and legal firm. The firm is led by Managing Partner, Kabiito Karamagi. The addition of Ligomarc Advocates as a Collaborating Firm of Andersen Global continues the organization’s expansion in Africa. Ligomarc is Andersen Global’s fourth location in Africa. “Integrity, excellence, and putting the client at the center have always been of paramount importance to us, and our collaboration with Andersen Global will allow us to ensure our clients receive the best-in-class service internationally,” commented Kabiito Karamagi. “The team at Andersen shares our values of outstanding, seamless client service and independence—this is a natural fit.” Ligomarc Advocates was founded as a sole practice over fifteen years ago by Ruth Sebatindira,

SIA Launches a New Digital Platform for Instant Payments21.11.2017 14:00Pressemelding

SIA launches “SIA EasyWay”, the new digital platform which allows banks and other payment service providers (PSPs) to manage at European level the instant payments available from 21 November on EBA Clearing’s RT1 infrastructure developed by SIA, in addition to all other SEPA payment and collection instruments. In fact, as of this date, citizens and companies in 34 countries in the Single Euro Payments Area (SEPA) are able to transfer and receive sums of up to €15,000 per individual transaction in less than 10 seconds through a service available 24 hours a day, 365 days a year, in line with the SEPA Instant Credit Transfer (transfer with real-time and irrevocable credit) scheme of the European Payments Council (EPC). “SIA EasyWay” was created with the aim of helping financial institutions and PSPs with adoption and management of SEPA instruments (such as SCTs and SDDs), of in

Keio Plaza Hotel Tokyo Hosts "Sky Jazz Night" Events in the "Premier Grand" Club Lounge21.11.2017 14:00Pressemelding

Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will host special jazz events for guests staying in our “Premier Grand” Club Floor on December 7, 8, 14, 15, and 16, 2017. A duo consisting of piano and contrabass artists will perform 30 minutes jazz sessions in our Club Lounge located on the 45th floor at 5:30p.m., 6:30p.m., and 7:30p.m. Guests listening to these jazz sessions can enjoy complimentary hors d’ oeuvres, and alcoholic and non-alcoholic beverages. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005017/en/ Club Floor "Premier Grand," Club Lounge (Photo: Business Wire) Our “Premier Grand” Club Floors were renovated and newly opened in December 2016, with guest rooms being fitted with various premium items

Biogen Appoints Jeff Capello as Executive Vice President and Chief Financial Officer21.11.2017 12:30Pressemelding

Biogen (Nasdaq: BIIB) announced today the appointment of Jeffrey D. Capello as Executive Vice President and Chief Financial Officer effective as of December 11, 2017. Mr. Capello will lead Biogen’s Business Planning, Tax, Treasury, Internal Audit, Accounting, and Investor Relations functions. He will report to Michel Vounatsos, CEO of Biogen, will be a member of the Executive Committee, and will be based in Cambridge, Mass. Mr. Capello brings 26 years of experience in finance. Most recently he was Executive Vice President and Chief Financial Officer of Beacon Health Options Inc. His previous experience includes founding and running his own company, Monomy Advisors, and serving as Chief Financial Officer of Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. Earlier in his career he was also a partner in the Boston and Amsterdam offices of PwC.

The Brightline Initiative Announces the Addition of Saudi Telecom Company - STC21.11.2017 12:20Pressemelding

The Brightline Initiative announced today that Saudi Telecom Company (STC) is joining the Brightline Initiative coalition to help advance the discipline of strategic initiative management and bridge gaps between enterprise strategy design and delivery. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005474/en/ Signature of Coalition agreement by STC Group CEO, Dr. Khaled Biyari and Brightline Executive Director Ricardo Vargas (Photo: Business Wire) The initiative’s agreement has been signed by STC Group CEO, Dr. Khaled Biyari and by Brightline Executive Director Ricardo Vargas. Launched early in 2017 by the Project Management Institute (PMI), the Boston Consulting Group (BCG) and the Agile Alliance, the Brightline Initiative is a non-commercial coalition dedicated to helping executives

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom